S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea
· Delayed Price · Currency is KRW 36,200
+400 (1.12%)
At close: Mar 6, 2026
S.Biomedics Revenue
S.Biomedics had revenue of 3.25B KRW in the quarter ending September 30, 2025, a decrease of -3.93%. This brings the company's revenue in the last twelve months to 16.96B, up 30.26% year-over-year. In the year 2024, S.Biomedics had annual revenue of 13.73B with 4.77% growth.
Revenue (ttm)
16.96B
Revenue Growth
+30.26%
P/S Ratio
24.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
420.48B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Y-Biologics | 3.61B |
| curacle co.,ltd. | 1.14B |
| NIBEC | 32.96B |
| Bio Solution | 8.27B |
| IntoCell | 1.68B |
| ABION | 1.03B |
| HansBiomed | 100.17B |
| Genome & Company | 25.95B |